Newsletters
Gift Membership
Become a member
Subscribe
Get app
Sign in
Take Scroll With You
Download the app to read our award-winning journalism on the go and stay up-to-date with our notifications.
Get the app
ANDROID
iOS
Gift Membership
Home
Common Ground
The India Fix
Eco India
The Latest
The Reel
Magazine
Video
Trending
Historical romance: In 1906, an Englishwoman is infatuated by the handsome Indian groom of her horse
Through a reader’s eyes: Bloomsday celebrations in James Joyce’s city, Dublin
Review: Rekha is the life and soul of Muzaffar’s Ali’s classic ‘Umrao Jaan’
‘Map of Memories’: Experimental poems resonate with the poet’s identity as migrant, scholar, thinker
Seven books by Ugandan scholar Mahmood Mamdani, father of NYC mayoral candidate Zohran Mamdani
In Bengaluru, an ancient play finds new voice in the world’s oldest living dramatic tradition
Bike taxis are exploding in India – but are facing government roadblocks
Resistance, rhythm and freedom: The jazz drummer who beat the odds in apartheid South Africa
Fiction: A scheme to unearth the ‘lost’ Saraswati river becomes an act of Hindu nationalist pride
Five ways you may be harming your liver
‘Mistry’ review: New ‘Monk’ in a newish bottle
‘A dry future powered by the sun’: Solar water pumps are draining India’s groundwater reserves
Sections
Politics
Culture
India
World
Film and TV
Music
Books and Ideas
Business and Economy
Science and Technology
In Pictures
Announcements
Bookshop
The Field
Pulse
Elections 2024
Lupin
United States is approving drugs by the dozen. Why is it worrying Indian pharma companies?
Sriram Iyer, qz.com
· Jan 07, 2018 · 07:30 pm
Lupin shares end 17% lower as US drug regulator issues warning letters for two manufacturing units
Scroll Staff
· Nov 07, 2017 · 03:57 pm
